tak 779 has been researched along with sb 656933 in 1 studies
| Studies (tak 779) | Trials (tak 779) | Recent Studies (post-2010) (tak 779) | Studies (sb 656933) | Trials (sb 656933) | Recent Studies (post-2010) (sb 656933) |
|---|---|---|---|---|---|
| 118 | 1 | 35 | 6 | 2 | 6 |
| Protein | Taxonomy | tak 779 (IC50) | sb 656933 (IC50) |
|---|---|---|---|
| C-X-C chemokine receptor type 2 | Homo sapiens (human) | 0.1921 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horuk, R; Pease, J | 1 |
1 other study(ies) available for tak 779 and sb 656933
| Article | Year |
|---|---|
Chemokine receptor antagonists.
Topics: Animals; Autoimmune Diseases; Humans; Receptors, Chemokine | 2012 |